Gobi Partners has made a pre-seed investment in Valiance Health Inc., a Malaysia-based AI healthcare company, to support the development of a standardized healthcare data platform aimed at improving cost transparency and operational efficiency in the Malaysian healthcare system.

Information on the target

Valiance Health Inc. is a Malaysia-based artificial intelligence (AI) healthcare company that is pioneering the development of the country's first large-scale standardized healthcare data platform. This innovative platform is designed to enhance cost transparency, operational efficiency, and patient outcomes within the Malaysian healthcare system. The recent pre-seed investment led by Gobi Partners through its SuperSeed II Fund marks a significant milestone as it represents Gobi's inaugural foray into healthcare AI investments in Southeast Asia.

Founded by Dr. Lutfi Fadil and Dr. Ridhwan Hassan, Valiance Health emerged from critical insights gained during Dr. Fadil's doctoral research at Harvard University. The company addresses the pervasive issue of data fragmentation in Malaysia's healthcare sector, which has historically hindered the adoption of value-based healthcare (VBHC) by creating barriers to effective measurement of outcomes and cost visibility.

Industry overview in the target’s specific country

The Malaysian healthcare industry is at a pivotal juncture, characterized by rising medical inflation and a pressing need for improved operational efficiencies. As the demand for healthcare services continues to grow, the existing systems face challenges relate